North Central Cancer Treatment Group — Rochester, Minnesota

North Central Cancer Treatment Group is a clinical research site located in Rochester, Minnesota, United States 55905.

Crixeo Health Trust Score: 73/100 (FAIR). This profile has not yet been claimed by the site owner.

North Central Cancer Treatment Group has participated in 24 clinical trials.

Therapeutic areas: Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma.

Sponsors: National Cancer Institute (NCI).

Sponsor Feasibility Report

Trust Score: 73/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for North Central Cancer Treatment Group?

North Central Cancer Treatment Group has a Crixeo Trust Score of 73/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has North Central Cancer Treatment Group conducted?

North Central Cancer Treatment Group has 24 clinical trials on record. Their work covers Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Gliosarcoma.

Is North Central Cancer Treatment Group accredited by Crixeo Health?

Yes — North Central Cancer Treatment Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about North Central Cancer Treatment Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.